Presynaptic dopaminergic function in the striatum of schizophrenic patients. (Q48802317)

15 February 2018

title

Presynaptic dopaminergic function in the striatum of schizophrenic patients. (English)

1 reference

15 February 2018

0 references

0 references

1 reference

1 reference

5

1 reference

15 February 2018

Eric Artiges

7

1 reference

15 February 2018

Marie-Laure Paillère Martinot

2

object named as

M L Paillère-Martinot

1 reference

15 February 2018

author name string

M H Dao-Castellana

1

1 reference

15 February 2018

P Hantraye

3

1 reference

15 February 2018

D Attar-Lévy

4

1 reference

15 February 2018

C Crouzel

6

1 reference

15 February 2018

A Féline

8

1 reference

15 February 2018

A Syrota

9

1 reference

15 February 2018

J L Martinot

10

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 February 1997

1 reference

15 February 2018

published in

Schizophrenia Research

1 reference

15 February 2018

volume

23

1 reference

15 February 2018

issue

2

1 reference

15 February 2018

page(s)

167-174

1 reference

15 February 2018

Amphetamine psychosis: behavioral and biochemical aspects.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Dopamine receptor subtype imbalance in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Fast nonsupervised 3D registration of PET and MR images of the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Nigrostriatal function in humans studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Central D2 receptors and negative symptoms of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Dopamine and the pharmacology of schizophrenia: the state of the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Physical characteristics of the ECAT 953B/31: a new high resolution brain positron tomograph

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Neuroleptic treatment is an unlikely cause of elevated dopamine in thalamus of schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Beyond the dopamine hypothesis. The neurochemical pathology of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2896%2900102-8

7 January 2021

10.1016/S0920-9964(96)00102-8

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

9061812

1 reference

15 February 2018